Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06630845Active, not recruiting
Open-label, single-arm trial, sponsored by University of California, San Francisco. Primary endpoint: Proportion of lesions characterized as positive at 6 months. Started Feb 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06630845.